Sonoma Pharmaceuticals Inc

Research Sonoma Pharmaceuticals Inc (SNOA) on Bullrun: market cap USD 2.21M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSNOA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 2.21M
• Financial periodFY2025
• RevenueUSD 14.29M
• Revenue growth12.2%
• Net income-USD 3.46M
• Free cash flow-USD 168.00K
• Gross margin38.2%

Valuation Snapshot

latest market cap is USD 2.21M.

About Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne;

Frequently asked questions

What is Sonoma Pharmaceuticals Inc's market cap?

Sonoma Pharmaceuticals Inc's market capitalization is USD 2.21M.

What does Sonoma Pharmaceuticals Inc do?

Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.